May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Relationship of Nuclear Factor Kappa B to Monocyte Chemotactic Protein–1 Expression in the Pathogenesis of Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • Y. Mitamura
    Department of Ophthalmology, Sapporo Medical University, Sapporo, Japan
  • C. Harada
    Department of Molecular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Japan
  • T. Harada
    Department of Molecular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Japan
  • Footnotes
    Commercial Relationships  Y. Mitamura, None; C. Harada, None; T. Harada, None.
  • Footnotes
    Support  Grant 17591846 from the Ministry of Education, Culture, Sports, Science and Technology of Japan
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1726. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Mitamura, C. Harada, T. Harada; Relationship of Nuclear Factor Kappa B to Monocyte Chemotactic Protein–1 Expression in the Pathogenesis of Proliferative Diabetic Retinopathy . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1726.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Molecular mechanism of epiretinal membranes (ERMs) formation in proliferative diabetic retinopathy (PDR) remains unclear. Monocyte chemotactic protein–1 (MCP–1) is one of the candidates responsible for recruiting macrophages into the eyes that has an important role in ERM formation. Because hyperglycemia condition induces MCP–1 expression under the control of transcription factor nuclear factor kappa B (NF–kB), we hypothesized a possibility that MCP–1 is regulated by NF–kB in PDR ERMs. Here, we examined colocalization of MCP–1 and NF–kB in PDR ERMs and performed in vitro studies.

Methods: : ERM samples were obtained during vitrectomy from 5 eyes with PDR and processed for immunohistochemical analysis. After Mueller glial cells were stimulated with glycated albumin, nuclear localization of active form of NF–kB p50 was examined and MCP–1 levels were quantified by ELISA. To elucidate the importance of two NF–kB binding sites for MCP–1 transcriptional regulation, we performed luciferase assay.

Results: : Immunohistochemical analysis revealed that MCP–1 protein is colocalized with active form of NF–kB p50 in glial cell components of ERMs. In vitro studies demonstrated that glycated albumin induces NF–kB activation and up–regulation of MCP–1 production in retinal glial cells. Luciferase assay indicated that both of two NF–kB binding sites at the enhancer region are necessary for MCP–1 promoter activity.

Conclusions: : These results suggest that MCP–1, under the regulation of NF–kB, is involved in the formation of ERMs following PDR.

Keywords: diabetic retinopathy • pathology: experimental • retinal glia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×